VIOLETTA NADINE BANCROFT, and GEORGE E. BANCROFT, Plaintiffs, v.
THE TECUMSEH PRODUCTS COMPANY, TECUMSEH DIVISION INSURANCE PLAN, through its
designated Plan Administrator, TECUMSEH PRODUCTS COMPANY, Defendant.
CIVIL ACTION NO. 95-40466
UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF MICHIGAN,
SOUTHERN DIVISION
949 F. Supp. 1294; 1996 U.S. Dist. LEXIS
19056
December 19, 1996, Decided
DISPOSITION: [**1]
Plaintiffs', VIOLETTA NADINE BANCROFT and GEORGE E. BANCROFT, motion for
summary judgment GRANTED in its entirety and the defendant's, THE TECUMSEH
PRODUCTS COMPANY, motion for summary judgment DENIED in its entirety.
COUNSEL: For Tecumseh Prod Co, dft:
Shari M. Borsini, Dickinson, Wright, Bloomfield Hills, MI.
For George E. Bancroft, pla:
Laurie S. Longo, Ann Arbor, MI.
JUDGES: HONORABLE PAUL V. GADOLA,
U.S. DISTRICT JUDGE
OPINION BY: PAUL V. GADOLA
OPINION:
[*1295] MEMORANDUM OPINION AND ORDER GRANTING
PLAINTIFFS' MOTION FOR SUMMARY JUDGMENT AND DENYING DEFENDANT'S MOTION FOR
SUMMARY JUDGMENT
This is an action governed by the Employee Retirement Income
Security Act of 1974 ("ERISA"), 29 U.S.C. § 1001 et seq. Before the court are
cross-motions for summary judgment pursuant to Federal Rule of Civil
Procedure 56(c). Plaintiffs, Violetta and George Bancroft,
("Plaintiffs"), filed their motion for summary judgment on October
18, 1996. The defendant, Tecumseh Products Company, ("Defendant"), also
filed its motion for summary judgment on October 18, 1996. Oral argument was
heard on December 11, 1996. For the reasons discussed below, this court will
grant plaintiffs' motion [*1296] for summary judgment [**2] and deny the defendant's motion for summary
judgment.
I. Background
Mrs. Bancroft is a covered beneficiary of the ERISA health benefit
plan for hourly retirees that is sponsored by her husband's employer, Tecumseh
Products Company. Prior to corrective surgery plaintiff suffered from macromastia
n1 causing severe and chronic back and neck pain, significant stoop, shoulder
grooving and paresthesia of the arms. She consulted several physicians, all of
whom agreed that her problem could be resolved through a reduction mammaplasty
or breast reduction surgery. Plaintiff and her physicians requested coverage
for the procedure from the defendant through her husband's pension plan but
were denied because the defendant determined that the procedure was not medically
necessary under its interpretation of the plan. n2
n1 Macromastia is an enlargement of the breasts caused by hormonal
factors or obesity.
n2 The relevant plan language provides:
Covered
charges include only those incurred for services or items specifically
recommended by a licensed physician as necessary for the diagnosis, care or
treatment of a physical or mental condition, and falling within Plan
guidelines.
For a
service to be determined as necessary for medical care, it must be widely
accepted by medical professionals in the United States as effective,
appropriate and essential under recognized health care standards. (emphasis
added)
[**3]
Tecumseh Products has designated Aetna Life Insurance Company as
its claim administrator. n3 Accordingly, Aetna has been delegated the
responsibility for determining whether a requested service is medically
necessary.
n3 Benefits paid from this ERISA plan are paid by the employer,
Tecumseh Products -- not by Aetna.
At the time she submitted her claim for preauthorization,
plaintiff was a sixty year old woman with a height of 5'6" and a weight of
218 pounds. On January 27, 1994, Dr. Paul H. Izenberg ("Dr.
Izenberg"), plaintiff's surgeon, submitted a request to Tecumseh Products
for preauthorization of reduction mammoplasty on behalf of Mrs. Bancroft. Dr.
Izenberg's request indicated that plaintiff exhibited chronic neck and back
pain and shoulder grooving, she had difficulty lifting or pinching, that her
breast size limited her activity, and that a reduction mammaplasty would
relieve those symptoms. Sue Ellen Sedery ("Sedery") Senior Cost
Containment Analyst at Aetna, processed the request and performed Aetna's
[**4] initial evaluation of whether
breast reduction surgery was medically necessary for Mrs. Bancroft. Ms. Sedery
consulted Aetna's on-line system (the "Central Health Policy Library"
or "CHPL") which contains the guidelines that are used by all Aetna
employees to evaluate an identified diagnosis for medical necessity. The CHPL
guidelines provide for preauthorization or coverage of breast reduction surgery
when medical necessity is documented by at least one of the following
conditions prior to surgery:
1. severe
pain in the breast not relieved by conservative measures (e.g. proper brassiere
support) or withdrawal of the cause of the pain and/or drug therapy.
2. severe
upper back and/or shoulder pain determined not to be of musculoskeletal origin
(e.g., arthritis, spondylitis) and not relieved by an adequate trial of conservative
measures (e.g. proper brassiere support, physical therapy, postural modifications,
etc.; if the patient is obese, weight loss.)
3. skin
breakdown (massive infection, tissue necrosis, slough, ulceration, and/or
hemorrhage) overlying breast or inframammary fold not relieved or controlled by
dermatological treatments and conservative measures.
[**5]
(emphasis added).
The CHPL guidelines require disapproval of preauthorization or
coverage if:
(1) the
primary purpose and/or result of the operation is to improve, alter or enhance
appearance for psychological, emotional or other reasons;
(2) when
the patient is more than 20% over ideal body weight (refer to ideal weight
chart in CCM 0089 n4);
[*1297]
(3) or delivery is imminent in the presence of gigantomastia of pregnancy.
(emphasis added)
n4 "CCM 0089" stands for Claim Committee Minute 089
Following the provisions set forth in the CHPL guidelines, Ms.
Sedery requested the following information from Dr. Izenberg on March 4, 1994:
Mrs. Bancroft's history and physical condition, his office notes, and
pre-operative photographs. On March 28, 1994, Dr. Izenberg provided Aetna with
his office notes and pre-operative photographs. He also informed Aetna that
Mrs. Bancroft was 5'6" with a weight of 218 pounds.
After receiving this information, Ms. Sedery determined that
surgery was not medically [**6]
necessary because Mrs. Bancroft was more than 20% over her maximum ideal
weight as set forth in Claim Committee Minute 089. For this reason, Ms. Sedery
denied Mrs. Bancroft's request for preauthorization in a letter dated April 6,
1994.
On June 20, 1994, Aetna received Mrs. Bancroft's first request for
reconsideration of the benefits determination. Along with her request, Mrs.
Bancroft provided four letters for review: the letter from Dr. Izenberg that
was submitted with her initial request for preauthorization. A letter from
James R. Gilsdorf, M.D. ("Dr. Gilsdorf") a general surgeon, dated
April 15, 1994, who had examined plaintiff and stated that he had observed in
plaintiff a significant stoop caused by the macromastia, that he had concern
regarding the weight of her breasts causing upper extremity paraesthesia, and
that her surgery could not be considered cosmetic. A letter from Anne Benedict
of Child & Family Service dated May 4, 1994. A letter form Charles R. Lyon,
D.O. ("Dr. Lyon"), dated May 23, 1994, plaintiff's family physician
for many years, who stated that plaintiff had chronic back and arm pain for
several years, had significant mammary hypertrophy and that the reduction
[**7] mammaplasty would relieve her back
pain. On July 7, 1994, Mrs. Bancroft's request for preauthorization was
referred to Dr. Thomas Felger, an independent medical examiner for
consideration of medical necessity. Based upon the materials submitted by
plaintiff, Dr. Felger determined that breast reduction surgery was not a
medically necessary service, due to Mrs. Bancroft's weight of 218 pounds. n5 On
August 8, 1994, Ms. Sedery again denied Mrs. Bancroft's request.
n5 Dr. Felger's documented analysis and conclusion consisted of
only the written statement "At 218 lbs - No".
On August 9, 1994 Tecumseh Products forwarded two additional
medical opinions that were allegedly related to plaintiff's breast reduction
surgery and again requested reconsideration of Aetna's decision to deny
preauthorization for the surgery. On August 16, 1994, Ms. Sedery forwarded the
claim file to Dr. Charles Polivy of Aetna's Medical Review Unit for review by
the Medical Director.
After his review of all the materials submitted by Mrs. Bancroft
[**8] and her physician, Dr. Polivy concluded
that the proposed treatment was not medically necessary. Specifically, Dr.
Polivy noted:
Sixty
year old female with orthopedic and neurosurgical evaluations by two specialists
note only lower back lumbar spinal stenosis. No upper back or cervical findings
mentioned. Previous compression syndrome of the wrist and hand do not reflect
neck and upper thoracic pathology. Plastic surgeon notes patient requests facial
cosmesis with reduction mammoplasty.
The age
of the patient would certainly explain some of the upper torso complaints with
5'6" 218 pounds. No back x-rays to confirm upper body contour and shoulder
levels or back. No photos AP or lateral. No intertrigo recorded as findings and
fails the guidelines. Would consider this cosmetic rather than functions.
(emphasis added)
Ms. Sedery again informed Dr. Izenberg in a letter dated August
18, 1994, that Aetna had concluded that Mrs. Bancroft's request for breast
reduction surgery was not a medically necessary service and that the surgery was
not a covered benefit. This was Aetna's
[*1298] final denial of Mrs.
Bancroft's request for preauthorization of breast reduction surgery. Plaintiff
[**9] and her husband obtained a
personal loan to pay for the procedure. Mrs. Bancroft underwent the procedure
on October 10, 1994. Following the procedure, Mrs. Bancroft requested that
defendants reimburse plaintiffs for the cost of the surgery. Aetna has
continued to deny Mrs. Bancroft' request for coverage of this procedure on the
basis of the exclusion of coverage for "cosmetic" surgery.
II. Summary Judgment Standard
Rule 56(c) of the Federal Rules of Civil Procedure provides that summary
judgment "shall be rendered forthwith if the pleadings, depositions,
answers to interrogatories, and admissions on file, together with the affidavits,
if any, show that there is no genuine issue as to any material fact and that
the moving party is entitled to judgment as a matter of law." Summary
judgment is appropriate where the moving party demonstrates that there is no
genuine issue of material fact as to the existence of an essential element of
the non-moving party's case on which the non-moving party would bear the burden
of proof at trial. Martin v. Ohio
Turnpike Commission, 968 F.2d 606, 608 (6th Cir. 1992); Celotex Corp. v.
Catrett, 477 U.S. 317, 322, 91 L. Ed. 2d 265, 106 S. Ct. 2548 [**10]
(1986). In considering a motion for summary judgment, the court must
view the facts and draw all reasonable inferences therefrom in a light most
favorable to the non-moving party. 60 Ivy Street Corporation v. Alexander,
822 F.2d 1432, 1435 (6th Cir. 1987). The court is not required or
permitted, however, to judge the evidence or make findings of fact. Id. at
1435-36. The moving party has the burden of showing conclusively that no
genuine issue of material fact exists. Id. at 1435.
A fact is "material" for purposes of summary judgment
where proof of that fact would have the effect of establishing or refuting an
essential element of the cause of action or a defense advanced by the
parties. Kendall v. Hoover Co., 751
F.2d 171, 174 (6th Cir. 1984). In other words, the disputed fact must be
one which might affect outcome of the suit under the substantive law controlling
the issue. Henson v. National
Aeronautics and Space Administration, 14 F.3d 1143, 1148 (6th Cir. 1994). A
dispute over a material fact is genuine "if the evidence is such that a
reasonable jury could return a verdict for the non-moving party." Id.
Accordingly, where a reasonable jury could [**11] not find that the non-moving party is
entitled to a verdict, there is no genuine issue for trial and summary judgment
is appropriate. Feliciano v. City of Cleveland, 988 F.2d 649 (6th Cir.
1993).
Once the moving party carries its initial burden of demonstrating
that no genuine issues of material fact are in dispute, the burden shifts to
the non-moving party to present specific facts to prove that there is a genuine
issue for trial. To create a genuine issue of material fact, the non-moving
party must present more than just some evidence of a disputed issue. As the
United States Supreme Court stated in Anderson v. Liberty Lobby, Inc., 477
U.S. 242, 249-50, 91 L. Ed. 2d 202, 106 S. Ct. 2505 (1986):
There is
no issue for trial unless there is sufficient evidence favoring the non-moving
party for a jury to return a verdict for that party. If the [non-moving
party's] evidence is merely colorable, or is not significantly probative,
summary judgment may be granted.
(Citations omitted); see also
Celotex, 477 U.S. at 322-23; Matsushita Elec. Indus. Co. v. Zenith
Radio Corp., 475 U.S. 574, 586-87, 89 L. Ed. 2d 538, 106 S. Ct. 1348 (1986).
Consequently, the [**12] non-moving
party must do more than raise some doubt as to the existence of a fact; the
non-moving party must produce evidence that would be sufficient to require
submission of the issue to the jury. Lucas v. Leaseway Multi Transp. Serv.,
Inc., 738 F. Supp. 214, 217 (E.D. Mich. 1990), aff'd, 929 F.2d 701 (6th
Cir. 1991).
III. Standard of Review
If an employee benefits plan gives a plan administrator the
discretionary authority to determine eligibility for benefits or to construe
the terms of the plan, then a district court reviews the decision to deny
benefits under an arbitrary and capricious
[*1299] standard. Firestone
Tire and Rubber co. v. Bruch, 489 U.S. 101, 115, 103 L. Ed. 2d 80, 109 S. Ct.
948 (1989). See also Livingston v. Central States, 900 F. Supp. 108
(E.D. Mich. 1995). The Sixth Circuit has interpreted Firestone to require
that the plan "expressly" give discretionary authority to the administrator.
Johnson v. Eaton Corp., 970 F.2d 1569, 1571 (1992). The parties herein
agree that the plan under which plaintiff's claim was submitted does not
provide defendants nor their fiduciary with discretion to interpret or construe
the terms of the plan. The [**13]
standard of judicial review in this matter, therefore, is the de novo
standard rather than the arbitrary and capricious standard. Accordingly, this
court is to review Aetna's decision "without deference" and decide
whether it agrees with it, "based upon the record before the
administrator." Perry v. Simplicity Engineering, 900 F.2d 963, 966 (6th
Cir. 1990).
IV. Analysis
While not raised by the plaintiffs in their pleadings, this court,
at the outset, finds that defendant has violated ERISA by failing to comply
with the procedural requirements of section 1133. n6 Section 1133 provides:
In
accordance with regulations of the Secretary, every employee benefit plan
shall--
(1)
provide adequate notice in writing to any participant or beneficiary whose
claim for benefits under the plan has been denied, setting forth the reasons
for such denial, written in a manner calculated to be understood by the
participant, and
(2)
afford a reasonable opportunity to any participant whose claim for benefits has
been denied for a full and fair review by the appropriate named fiduciary of
the decision denying the claim.
The regulations promulgated
under this section require [**14] that
the written notice of denial include:
(1) The
specific reason or reasons for the denial;
(2)
Specific reference to pertinent plan provisions on which the denial is based;
(3) A
description of any additional material or information necessary for the
claimant to perfect the claim and an explanation of why such material or information
is necessary; and
(4)
Appropriate information as to the steps to be taken if the participant or
beneficiary wishes to submit his or her claim for review.
29 C.F.R. §
2560.503-1(f) (emphasis added). In the present case, all three
letters notifying plaintiff that her claim had been denied failed to comply
with 29 C.F.R. § 2560.503-1(f).
Those letters, dated April 6, 1994, August 8, 1994 and August 18, 1994
substantially read as follows:
This is
to advise you that the proposed treatment as described in your letter, bilateral
reduction mammoplasty (CPT 19318), would not appear to be a covered expense.
The benefits plan under which this patient is insured excludes coverage of
expenses for services or supplies that are not necessary for the treatment of
an accidental bodily injury or disease.
Our
decision in this [**15] matter is based
on our interpretation of the treatment plan as described in your correspondence,
and on the current plan of benefits. The decision as to whether or not to proceed
with this treatment is, of course, strictly between the patient and you.
n6 Plaintiffs' counsel did raise this issue at oral argument.
However, this court had, prior to the hearing, conducted its own research and
analysis on the issue of a procedural violation of ERISA and was not persuaded
by either party's remarks at oral argument.
With respect to the first requirement under § 2560.503-1(f), the mere statement of the
conclusion that "the proposed treatment ... would not appear to be a covered
expense" because it is "not necessary" does not constitute a
"specific reason" for the denial, as that term is used in the
regulations. VanderKlok v. Provident
Life and Accident Ins. Co., 956 F.2d 610, 616-17 (6th Cir. 1992); Rakoczy
v. Travelers Ins. Co., 914 F. Supp. 166, 171 (E.D. Mich. 1996). The
notification merely stated that [**16]
the defendant believed that the treatment was not covered under its
interpretation of the plan instead of informing the plaintiff of why defendant so
believed. See [*1300] Grossmuller v. Int'l Union, 715 F.2d 853,
858 (3d Cir. 1983). This requirement could have been satisfied by notifying
plaintiff of the defendant's interpretation of the Plan's "effective,
appropriate and essential" language, the specific evidence upon which the
defendant based its conclusion, and why the defendant believed the evidence
supported its conclusions. See id. Specifically, the defendant should have notified
plaintiff of their guidelines for determining whether breast reduction surgery
is medically necessary and then notified her that they believed that her
condition did not satisfy any of those guidelines and what evidence supported
their conclusion.
With respect to the third requirement, defendant's notification
did not provide plaintiff with a description of the material or information
that plaintiff should adduce to perfect her claim or an explanation of why such
information would be helpful, to wit: the defendant should have informed
plaintiff that she needed to first try more "conservative
treatments," [**17] i.e. weight loss, before undergoing a breast
reduction operation.
Although the remedy for a violation of ERISA procedures is
generally a remand to the defendant for a full and fair review of its denial,
see Wolfe v. J.C. Penney, Inc., 710 F.2d 388, 393 (7th Cir. 1983), in
the instant case, such a remand would clearly be futile. It cannot be expected
that plaintiff would now be able to proffer evidence that she attempted weight
loss prior to undergoing her breast reduction as there is no reason to believe
that she knew that she was required to provide such evidence at that time. The
time to proffer that evidence would have been upon a proper denial of benefits
by the defendant that informed her of that requirement. That, of course, can no
longer occur in this case.
The Sixth Circuit in Vanderklok recognized that a remand to the
defendant is not always the required remedy for a procedural violation of
ERISA. Vanderklok, 956 F.2d at 617. The Sixth circuit stated:
"Because [the defendant] failed to give appropriate notice, it is not entitled
to the protections concerning administrative review which form the basis of
Perry." Instead, the Vanderklok court [**18] permitted the district court to conduct the
review and allowed plaintiff to submit additional evidence. Id. As such, this
court will consider those materials submitted by plaintiff concerning the
prevailing standard of medical practice even though that evidence was not
before the administrator.
After conducting a de novo review of the administrator's decision,
this court finds that the defendant improperly denied plaintiff benefits under
the plan.
First, this court finds that the defendant did not adhere to its
own Plan guidelines. Clinical Policy 93-5, which pertains to reduction
mammaplasty, requires that:
ANY FINAL
DECISION WILL BE MAKE BY A REVIEW PHYSICIAN BASED ON HIS/HER CLINICAL
KNOWLEDGE, KNOWLEDGE OF THE CURRENT SCIENTIFIC LITERATURE PERTINENT TO THE
GIVEN DIAGNOSIS, AND THE MEDICAL CONDITION OF THE PATIENT IN QUESTION
(emphasis added) At
deposition, however, Dr. Polivy, the reviewing physician admitted that he had
no current clinical experience for the medical condition at issue and that he
had not stayed current with the medical literature addressing that condition.
As to Dr. Polivy's "clinical experience," Dr. Polivy testified that
he had [**19] not performed a reduction
mammaplasty of any kind since "1950 or 1960." As to Dr. Polivy's
knowledge of current literature, he testified that he had not read any journal
articles on reduction mammaplasty in the last five years, had never heard of
the textbook Reduction Mammaplasty and was not familiar with any of the medical
literature correlating weight management with treatment for macromastia during
the last ten years. Moreover, Dr. Polivy was unable to support any of his
medical opinions with specific reference to medical literature, current or otherwise.
As such, Dr. Polivy's review cannot reasonably be said to meet any basic
qualifications under the Plan or under the applicable policy guidelines.
In addition, it appears that when plaintiff met with her plastic
surgeon regarding [*1301] breast reduction surgery, she also inquired
about a facelift. Dr. Polivy acknowledged that plaintiff's inquiry of her
physician concerning facelifts "had a great influence on his decision"
to deny coverage. Consideration of that information is not authorized under any
guideline and was irrelevant to a proper evaluation of the necessity for
plaintiff's surgery. It does not follow that simply because [**20] plaintiff made a brief inquiry regarding
facelift surgery while consulting with her surgeon about relief for her
macromastia, that, therefore her interest in a reduction mammaplasty is merely
cosmetic.
Second, despite defendants contentions to the contrary, that
plaintiff failed to provide objective medical evidence showing that she fell
into any to the three categories set forth in Clinical Policy 93-5, the record
is replete with objective evidence of functional symptoms of macromastia as
observed independently by three physicians. For instance, Dr. Gilsdorf, a
general surgeon who had examined plaintiff, stated that he had observed a
significant stoop in plaintiff caused by the macromastia, that he had concern
regarding the weight of her breasts causing upper extremity paresthesia, and
that her surgery could not be considered cosmetic. In addition, Dr. Lyon,
plaintiff's family physician for many years, stated that plaintiff has had
chronic back and arm pain for several years, had significant mammary
hypertrophy and that the reduction mammaplasty would relieve her back pain.
Finally, Dr. Izenberg, plaintiff's surgeon indicated that plaintiff exhibited
chronic neck and back pain and [**21]
shoulder grooving, she had difficulty lifting or pinching, that her
breast size limited her activity, and that a reduction mammaplasty would
relieve these symptoms. Instead, defendant, without itself conducting a physical
examination of plaintiff, elected to discount the findings of the examining
physicians and surgeon and deny plaintiff benefits.
Finally, the defendant's conclusion that "standard medical
practice requires that a patient who exceeds her maximum ideal weight by more
than 20% first attempt to reduce the size of her breasts by trying conservative
measures, for example weight reduction, prior to surgery," is not well
founded. Nowhere in defendant's supporting exhibits are they able to point to
such a definitive medical standard. The best defendant can do is a reference to
a 1989 book by Seymour Schwartz entitled Principles of Surgery, which states:
"Obesity is a common finding [upon preforming a breast examination for macromastia],
and the patient is advised to lose weight before considering surgery."
Defendant also refers to a 1986 article by Michael Pers that concludes, after
treating 198 overweight patients (out of a total of 365 patients), that:
"Primary complications [**22] from
breast reduction surgery were more frequent in overweight patients, and
preoperative weight regulation is recommended." n7 However, neither of
these references support the defendant's conclusion that a patient who exceeds
her maximum ideal weight by more than 20% must first attempt weight reduction
prior to surgery.
n7 Interestingly, that study also concluded that "reduction
mammaplasty is not essentially cosmetic, but rather relieves the patient of
real discomfort."
On the other hand, plaintiff proffers a bevy of recent studies which
conclude, irrespective of obesity or lack thereof, that breast reduction is an
effective treatment to relieve back and neck pain. For instance, Dr. Federico
Gonzalez, et al. in a June, 1993 article entitled Reduction Mammaplasty
Improves Symptoms of Macromastia, in the Journal of Plastic and Reconstructive
Surgery concluded that:
The data presented in this study demonstrate that reduction
mammaplasty significantly decreases both the frequency and severity of pain and
[**23] discomfort in macromastia patients
to equivalent or lower levels than present in a control population. The
cumulative pain symptoms of each patient in our study were diminished by
reduction mammaplasty surgery, and pain and discomfort were totally eliminated
in 25 percent of patients.
* * *
Symptom improvement with reduction mammaplasty was independent of
patient height/weight ratios. The notion that a tall, thin patient with
macromastia should [*1302] benefit more from reduction mammaplasty than
a shorter, heavier patient has never been demonstrated and is not borne out by
our results. This raises the question regarding weight loss as an effective
therapy for macromastia. Although weight loss is often prescribed, it has never
been demonstrated to reduce the pain symptoms of macromastia patients. While
our study does not specifically address the issue of weight loss, our study
group contained individuals of numerous body types, and all were improved symptomatically
by the reduction mammaplasty procedure.
Id. at p. 1274. Also in the
Journal of Plastic and Reconstructive Surgery, a December 30, 1993 article
entitled Breast Reduction for Symptomatic Macromastia: Can Objective [**24]
Predictors for Operative Success Be Identified? by Dr. Anne P. Miller et
al. which stated that:
What was
clear was that those patients with physical symptoms of macromastia--headache,
neck, shoulder, and back pain, rashes beneath the breast, deep bra strap
grooves, and low backache--were almost always improved by reduction mammaplasty.
These patients frequently attained a more normal body weight, often ceased to
use pain medication, and increased their activity levels.
CONCLUSION
It would appear that until a more objective tool can be developed
to define potential candidates for surgery, any patient having the standard
symptoms associated with macromastia should be considered a candidate for
reduction mammaplasty regardless of the amount of tissue to be removed.
Id. at p. 82. (emphasis) It
is evident from these references and others n8 that reduction mammaplasty is
considered an effective treatment for plaintiff's symptoms irrespective of her
weight. While it is true that none of these references specifically addresses
the issue of weight loss, it cannot be said that any of the defendant's
references does either. As such, the issue of whether weight loss [**25] must be attempted prior to breast reduction
is, at least, an open question while the benefits of such a reduction, to any
person, has been resoundingly proven. Therefore, this court finds that the
defendant's reliance on their conclusion that accepted medical practice
required plaintiff to first address her breast size by trying a more safe and
conservative measure, such as weight loss, was improper.
n8 A study published in the Annals of Plastic Surgery which
examined the effect of reduction mammaplasty on long-term morbidity related to
chronic neck and back pain concluded that seventy-four percent of patients were
free of neck pain postoperatively versus 21% preoperatively. The study noted
that similar results were obtained regarding back pain. The study also noted
that 81% of those reporting severe neck or back pain before surgery had only
mild or no pain after surgery.
V. Conclusion
In sum, this court concludes that the defendant improperly denied,
as not medically necessary, plaintiffs' request for [**26] coverage under the benefits plan.
ORDER
IT IS HEREBY ORDERED that the plaintiffs', VIOLETTA NADINE BANCROFT and GEORGE E.
BANCROFT, motion for summary judgment is GRANTED in its entirety and the
defendant's, THE TECUMSEH PRODUCTS COMPANY, motion for summary judgment is DENIED
in its entirety.
IT IS HEREBY FURTHER ORDERED that defendant, THE TECUMSEH PRODUCTS COMPANY PAY
plaintiffs, VIOLETTA NADINE BANCROFT and GEORGE E. BANCROFT, benefits due under
the Plan, including interest from the date of plaintiff's reduction
mammaplasty.
IT IS HEREBY FURTHER ORDERED that defendant, THE TECUMSEH PRODUCTS COMPANY PAY
plaintiffs, VIOLETTA NADINE BANCROFT and GEORGE E. BANCROFT, their COSTS
and FEES, including reasonable attorney's fees.
SO ORDERED.
Dated: 12/19/96
PAUL V. GADOLA
UNITED STATES DISTRICT JUDGE
[*1303] JUDGMENT
This action came before this court, the Honorable Paul V. Gadola,
District Judge presiding, and the issues having been fully presented and the
court being fully advised in the premises, and a decision having been duly
rendered,
IT IS HEREBY ORDERED AND ADJUDGED that the defendant, [**27]
THE TECUMSEH PRODUCTS COMPANY PAY plaintiffs, VIOLETTA NADINE
BANCROFT and GEORGE E. BANCROFT, benefits due under the Plan, including
interest from the date of plaintiff's reduction mammaplasty.
IT IS HEREBY FURTHER ORDERED AND ADJUDGED that defendant, THE TECUMSEH
PRODUCTS COMPANY PAY plaintiffs, VIOLETTA NADINE BANCROFT and GEORGE E.
BANCROFT, their COSTS and FEES, including reasonable attorney's
fees.
IT IS FURTHER ORDERED that the clerk of the court serve a copy of this judgment by
United States mail on counsel for the parties named in the caption above.
SO ORDERED.
Dated: 12/20/96
PAUL V. GADOLA
UNITED STATES DISTRICT JUDGE